Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Tensive Srl |
| Country | Italy |
| Start Date | Mar 01, 2023 |
| End Date | Feb 28, 2025 |
| Duration | 730 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190163787 |
Of the 3 million women undergoing breast cancer resection every year, only a few opt for breast reconstruction due to pain, concerns about follow-up procedures and the lack of options. For lumpectomy patients traditional implants cannot be used, with only ~20-30% of lumpectomies being reconstructed.
Autologous tissue transfer requires multiple painful interventions to reconstruct large volumes and obtain satisfactory results.
Furthermore, both implants and autologous solutions require multiple follow-up surgeries, increasing costs and pain for the patients.
REGENERA will be a unique solution for lumpectomy patients: a resorbable implant designed to restore a natural breast through tissue self-regeneration.
It is a cell-free porous scaffold made of resorbable biocompatible poly(urethane-ester-ether) with a biomimetic architecture.
It is designed to avoid follow-up surgeries and eliminate the risks associated with silicone and saline implants (rupture, leakage, ALCL) and fat grafting.
Tensive Srl
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant